Octapharma Receives Orphan Drug Exclusivity Approval for wilate(R … FOXBusiness “Orphan drug exclusivity confirms Octapharma’s decision to focus exclusively on the treatment of von Willebrand patients. Wilate has a combination of two … |
||
Octapharma Receives Orphan Drug Exclusivity Approval for wilate(R … | ||
 |
||
 |